BUSINESS● LOW22h ago · Oct 14, 2026, 9:06 AM
Aurobindo joins speciality pharma race as Indian drugmakers return to branded US play
moneycontrol · india · global
Aurobindo's speciality push is being led through Acrotech Biopharma, a step-down subsidiary focused on innovative and proprietary medicines
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More from india
POLITICS28m agoIndia news: Supreme Court hears Rahul Gandhi's Election Commission pleaDW News [en]BUSINESS52m agoIMF backs India's updated GDP methodology, calls revision 'welcome development'The HinduPOLITICS58m agoMumbai Police ask actor Imran Khan to leave India by October 28The HinduBUSINESS1h agoIndia’s IDBI Bank falls 7% as government announces $5.5 billion stake sale to Canada's FairfaxCNBC
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowFormula 1: Can Kagame's financial gamble pay off?Jeune AfriqueBUSINESS22m agoEarnings Snapshot: Taiwan Semiconductor Manufacturing tops Q3 estimates, gives Q4 revenue guidance above estimatesSeeking Alpha Tech